Anovel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride

International Journal of Nanomedicine

Volumn 12, Issue , 2017, Pages 1731-1745

  Huang, Yi ^a   Tao, Qi ^b   Hou, Dong Zhi ^a   Hu, Sheng ^a   Tian, Shuang Yan ^a   Chen, Yan Zhong ^a   Gui, Ruyi ^a   Yang, Ling Ling ^c   Wang, Yao ^d  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d SHANDONG EYE INSTITUTE   (China)

Author keywords

Intraocular optical pressure; Irritation; Liposome; Montmorillonite; Precorneal retention time

Indexed keywords

ALCOHOL; AMMONIUM SULFATE; BETAXOLOL; LIPOSOME; MONTMORILLONITE; BENTONITE; NANOCOMPOSITE; SOLUTION AND SOLUBILITY;

ACIDIFICATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG HALF LIFE; DRUG RETENTION; DRUG SOLUTION; DRUG STABILITY; ENCAPSULATION; EYE IRRITATION; FEMALE; HEN; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; LACRIMAL FLUID; MEAN RESIDENCE TIME; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PARTICLE SIZE; PHARMACODYNAMICS; SINGLE DRUG DOSE; SLOW DRUG RELEASE; SUSTAINED DRUG RELEASE; ZETA POTENTIAL; ANIMAL; CELL SURVIVAL; CHEMISTRY; CORNEA; DIALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG RELEASE; EYE; FROZEN SECTION; INFRARED SPECTROSCOPY; ION EXCHANGE; PATHOLOGY; PATHOPHYSIOLOGY; RABBITS AND HARES; SOLUTION AND SOLUBILITY; THERMOGRAVIMETRY; TIME FACTOR; X RAY DIFFRACTION;

ANIMALS; BENTONITE; BETAXOLOL; CALORIMETRY, DIFFERENTIAL SCANNING; CELL SURVIVAL; CORNEA; DIALYSIS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; EYE; FROZEN SECTIONS; HUMANS; INTRAOCULAR PRESSURE; ION EXCHANGE; LIPOSOMES; NANOCOMPOSITES; PARTICLE SIZE; RABBITS; SOLUTIONS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERMOGRAVIMETRY; TIME FACTORS; X-RAY DIFFRACTION;

EID: 85014572357     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S122747     Document Type: Article

References (52)

1. Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Ophthalmology. 2008;115(7):1123–1129.
2. Jung HJ, Abou-Jaoude M, Carbia BE, Plummer C, Chauhan A. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses. J Control Release. 2013;165(1):82–89.
3. Gallarate M, Chirio D, Bussano R, et al. Development of O/W nanoemulsions for ophthalmic administration of timolol. Int J Pharm. 2013;440(2):126–134.
4. Huang W, Zhang N, Hua H, et al. Preparation, pharmacokinetics and pharmacodynamics of ophthalmic thermosensitive in situ hydrogel of betaxolol hydrochloride. Biomed Pharmacother. 2016;83:107–113.
5. Davies NM. Biopharmaceutical considerations in topical ocular drug delivery. Clin Exp Pharmacol Physiol. 2000;27(7):558–562.
6. Dai Y, Zhou R, Liu L, Lu Y, Qi J, Wu W. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomedicine. 2013;8:1921–1933.
7. Chetoni P, Monti D, Tampucci S, et al. Liposomes as a potential ocular delivery system of distamycin A. Int J Pharm. 2015;492(1–2):120–126.
8. Zhang J, Liang X, Li X, et al. Ocular delivery of cyanidin-3-glycoside in liposomes and its prevention of selenite-induced oxidative stress. Drug Dev Ind Pharm. 2016;42(4):546–553.
9. Aksungur P, Demirbilek M, Denkbaş EB, Vandervoort J, Ludwig A, Unlü N. Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies. J Control Release. 2011;151(3):286–294.
10. Duxfield L, Sultana R, Wang R, et al. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery. Pharm Dev Tech. 2015;21(2):172–179.
11. Andrés-Guerrero V, Zong M, Ramsay E, et al. Novel biodegradable polyesteramide microspheres for controlled drug delivery in ophthalmology. J Control Release. 2015;211:105–117.
12. Osswald CR, Kang-Mieler JJ. Controlled and extended release of a model protein from a microsphere-hydrogel drug delivery system. Ann Biomed Eng. 2015;43(11):2609–2617.
13. Hippalgaonkar K, Adelli GR, Hippalgaonkar K, Repka MA, Majumdar S. Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. J Ocul Pharmacol Ther. 2013;29(2):216–228.
14. Leonardi A, Bucolo C, Drago F, Salomone S, Pignatello R. Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit. Int J Pharm. 2015;478(1):180–186.
15. Horvát G, Gyarmati B, Berkó S, et al. Thiolated poly(aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system. Eur J Pharm Sci. 2015;67:1–11.
16. Wu Y, Yao J, Zhou J, Dahmani FZ. Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels. Int J Nanomedicine. 2013;8:3587–3601.
17. Maulvi FA, Lakdawala DH, Shaikh AA, et al. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery. J Control Release. 2016;226:47–56.
18. Lajunen T, Hisazumi K, Kanazawa T, et al. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes. Eur J Pharm Sci. 2014;62:23–32.
19. Shafaa MW, Sabra NM, Fouad RA. The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits. Biopharm Drug Dispos. 2011;32(9):507–517.
20. Asasutjarit R, Theerachayanan T, Kewsuwan P, Veeranodha S, Fuongfuchat A, Ritthidej GC. Development and evaluation of diclofenac sodium loaded-N-trimethyl chitosan nanoparticles for ophthalmic use. AAPS Pharm Sci Tech. 2015;16(5):1013–1024.
21. Aguzzi C, Cerezo P, Viseras C, Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl Clay Sci. 2007;36(1–3):22–36.
22. Hou DZ, Hu S, Huang Y, et al. Preparation and in vitro study of lipid nanoparticles encapsulating drug loaded montmorillonite for ocular delivery. Appl Clay Sci. 2016;119(2):277–283.
23. Zheng JP, Luan L, Wang HY, Xi LF, Yao KD. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl Clay Sci. 2007;36(4):297–301.
24. Fejér I, Kata M, Erös I, Berkesi O, Dékány I. Release of cationic drugs from loaded clay minerals. Colloid Polym Sci. 2001;279(12):1177–1182.
25. Nunes CD, Vaz PD, Fernandes AC, Ferreira P, Romão CC, Calhorda MJ. Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur J Pharm Biopharm. 2007;66(3):357–365.
26. Hou DZ, Gui RY, Hu S, Huang Y, Zuyong Feng ZY, Ping QN. Preparation and characterization of novel drug-inserted-montmorillonite chitosan carriers for ocular drug delivery. Adv Nanopart. 2015;4(3):70–84.
27. Kevadiya BD, Joshi GV, Mody HM, Bajaj HC. Biopolymer-clay hydrogel composites as drug carrier: host-guest intercalation and in vitro release study of lidocaine hydrochloride. Appl Clay Sci. 2011;52(4):364–367.
28. Joshi GV, Kevadiya BD, Patel HA, Bajaj HC, Jasra RV. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int J Pharm. 2009;374(1–2):53–57.
29. Gandhi R, Khatri N, Baradia D, Vhora I, Misra A. Surface-modified epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7. Drug Deliv. 2016;23(4):1152–1162.
30. Yu Y, Lu Y, Bo R, et al. The preparation of gypenosides liposomes and its effects on the peritoneal macrophages function in vitro. Int J Pharm. 2014;460(1–2):248–254.
31. Vega E, Egea MA, Calpena AC, et al. Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery. Int J Nanomedicine. 2012;7:1357–1371.
32. Gokce EH, Sandri G, Bonferoni MC, et al. Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. Int J Pharm. 2008;364(1):76–86.
33. Buda I, Budai P, Szabó R, Lehel J. In vitro eye corrosion study of agrochemicals on isolated chicken eye. Commun Agric Appl Biol Sci. 2013;78(2):177–181.
34. Li J, Liu H, Liu LL, Cai CN, Xin HX, Liu W. Design and evaluation of a brinzolamide drug-resin in situ thermosensitive gelling system for sustained ophthalmic drug delivery. Chem Pharm Bull (Tokyo). 2014;62(10):1000–1008.
35. Nagai N, Yoshioka C, Mano Y, et al. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure. Exp Eye Res. 2015;132:115–123.
36. Zhang W, Li X, Ye T, et al. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. Int J Pharm. 2013;454(1):354–366.
37. Joshi GV, Kevadiya BD, Bajaj HC. Controlled release formulation of ranitidine-containing montmorillonite and Eudragit E-100. Drug Dev Ind Pharm. 2010;36(9):1046–1053.
38. Chiu CW, Chu CC, Cheng WT, Lin JJ. Exfoliation of smectite clays by branched polyamines consisting of multiple ionic sites. Eur Polym J. 2008;44(3):628–636.
39. Kevadiya BD, Thumbar RP, Rajput MM, et al. Montmorillonite/poly-(ε-caprolactone) composites as versatile layered material: reservoirs for anticancer drug and controlled release property. Eur J Pharm Sci. 2012;47(1):265–272.
40. Kevadiya BD, Patel TA, Jhala DD, et al. Layered inorganic nanocomposites: a promising carrier for 5-fluorouracil (5-FU). Eur J Pharm Biopharm. 2012;81(1):91–101.
41. Kevadiya BD, Chettiar SS, Rajkumar S, Bajaj HC, Gosai KA, Brahmbhatt H. Evaluation of clay/poly (l-lactide) microcomposites as anticancer drug, 6-mercaptopurine reservoir through in vitro cytotoxicity, oxidative stress markers and in vivo pharmacokinetics. Colloids Surf B Biointerfaces. 2013;112:400–407.
42. Tsai CC, Juang TY, Dai SA, et al. Synthesis and montmorillonite-intercalated behavior of dendritic surfactants. J Mater Chem. 2006;16(21):2056–2063.
43. Li SL, Jiang CX, Chen XM, Wang H, Lin J. Lactobacillus casei immobilized onto montmorillonite: survivability in simulated gastrointestinal conditions, refrigeration and yogurt. Food Res Int. 2014;64:822–830.
44. Kevadiya BD, Joshi GV, Patel HA, Ingole PG, Mody HM, Bajaj HC. Montmorillonite-alginate nanocomposites as a drug delivery system: intercalation and in vitro release of vitamin B1 and vitamin B6. J Biomater Appl. 2010;25(2):161–177.
45. Kevadiya BD, Joshi GV, Bajaj HC. Layered bionanocomposites as carrier for procainamide. Int J Pharm. 2010;388(1–2):280–286.
46. Iliescu RI, Andronescu E, Ghitulica CD, Voicu G, Ficai A, Hoteteu M. Montmorillonite-alginate nanocomposite as a drug delivery system: incorporation and in vitro release of irinotecan. Int J Pharm. 2014;463(2):184–192.
47. Kevadiya BD, Rajkumar S, Bajaj HC, et al. Biodegradable gelatin-ciprofloxacin-montmorillonite composite hydrogels for controlled drug release and wound dressing application. Colloids Surf B Biointerfaces. 2014;122:175–183.
48. Kaunisto E, Tajarobi F, Abrahmsen-Alami S, Larsson A, Nilsson B, Axelsson A. Mechanistic modelling of drug release from a polymer matrix using magnetic resonance microimaging. Eur J Pharm Sci. 2013;48(4–5):698–708.
49. Lawrence RS, Ackroyd DM, Williams DL. The chorioallantoic membrane in the prediction of eye irritation potential. Toxicol In Vitro. 1990;4(6):321–323.
50. Reinhardt CA, Pelli DA, Zbinden G. Interpretation of cell toxicity data for the estimation of potential irritation. Food Chem Toxicol. 1985;23(2):247–252.
51. Hagino S, Itagaki H, Kato S, Kobayashi T. Further evaluation of the quantitative chorioallantoic membrane test using trypan blue stain to predict the eye irritancy of chemicals. Toxicol In Vitro. 1993;7(1):35–39.
52. Giannola LI, de Caro V, Giandalia G, Siragusa MG, Cordone L. Ocular gelling microspheres: in vitro precorneal retention time and drug permeation through reconstituted corneal epithelium. J Ocul Pharmacol Ther. 2008;24(2):186–196.